Strs Ohio Buys Shares of 60,800 Viemed Healthcare, Inc. $VMD

Key Points

• Strs Ohio has acquired 60,800 shares of Viemed Healthcare, valued at approximately $443,000, increasing its stake to 0.15% of the company.
• Several institutional investors have significantly increased their holdings in Viemed Healthcare, with Apis Capital Advisors and others boosting their positions by 8.7% and up to 22.1% in the first quarter.
• Viemed Healthcare's recent quarterly earnings report showed an EPS of $0.08, meeting expectations, but revenue of $63.06 million fell short of the anticipated $63.50 million.

Strs Ohio bought a new stake in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 60,800 shares of the company's stock, valued at approximately $443,000. Strs Ohio owned 0.15% of Viemed Healthcare at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the company. Apis Capital Advisors LLC boosted its position in shares of Viemed Healthcare by 8.7% during the first quarter. Apis Capital Advisors LLC now owns 304,000 shares of the company's stock worth $2,213,000 after buying an additional 24,400 shares during the period. Northern Trust Corp boosted its position in shares of Viemed Healthcare by 1.8% during the fourth quarter. Northern Trust Corp now owns 286,818 shares of the company's stock worth $2,300,000 after buying an additional 5,090 shares during the period. Panagora Asset Management Inc. boosted its position in shares of Viemed Healthcare by 14.2% during the first quarter. Panagora Asset Management Inc. now owns 235,814 shares of the company's stock worth $1,717,000 after buying an additional 29,252 shares during the period. Russell Investments Group Ltd. boosted its position in shares of Viemed Healthcare by 16.6% during the first quarter. Russell Investments Group Ltd. now owns 200,789 shares of the company's stock worth $1,462,000 after buying an additional 28,584 shares during the period. Finally, Nuveen Asset Management LLC boosted its position in shares of Viemed Healthcare by 22.1% during the fourth quarter. Nuveen Asset Management LLC now owns 162,272 shares of the company's stock worth $1,301,000 after buying an additional 29,320 shares during the period. 74.24% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Viemed Healthcare

In related news, President Michael Moore sold 50,090 shares of the stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $7.33, for a total transaction of $367,159.70. Following the completion of the transaction, the president directly owned 126,343 shares of the company's stock, valued at approximately $926,094.19. This represents a 28.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Jerome Cambre sold 4,880 shares of the stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $7.32, for a total value of $35,721.60. Following the transaction, the vice president directly owned 84,191 shares of the company's stock, valued at $616,278.12. This trade represents a 5.48% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 97,922 shares of company stock valued at $703,886. Insiders own 20.00% of the company's stock.

Viemed Healthcare Stock Up 3.0%

VMD stock opened at $6.93 on Tuesday. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.48 and a quick ratio of 1.37. The stock has a market capitalization of $268.81 million, a P/E ratio of 20.38 and a beta of 1.38. The business has a 50-day moving average of $6.75 and a 200-day moving average of $6.85. Viemed Healthcare, Inc. has a fifty-two week low of $5.93 and a fifty-two week high of $9.81.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The company reported $0.08 EPS for the quarter, meeting the consensus estimate of $0.08. Viemed Healthcare had a return on equity of 10.38% and a net margin of 5.80%.The firm had revenue of $63.06 million during the quarter, compared to analysts' expectations of $63.50 million.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.